1. Home
  2. REPL vs ATLC Comparison

REPL vs ATLC Comparison

Compare REPL & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$1.79

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Logo Atlanticus Holdings Corporation

ATLC

Atlanticus Holdings Corporation

HOLD

Current Price

$66.43

Market Cap

797.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
REPL
ATLC
Founded
2015
1996
Country
United States
United States
Employees
N/A
576
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
692.8M
797.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
REPL
ATLC
Price
$1.79
$66.43
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$11.00
$90.00
AVG Volume (30 Days)
2.4M
53.5K
Earning Date
05-21-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
5.25
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$477.21
Revenue Next Year
N/A
$10.42
P/E Ratio
N/A
$9.74
Revenue Growth
N/A
N/A
52 Week Low
$2.68
$45.74
52 Week High
$13.24
$78.91

Technical Indicators

Market Signals
Indicator
REPL
ATLC
Relative Strength Index (RSI) 19.65 73.16
Support Level N/A $64.75
Resistance Level $8.82 $70.95
Average True Range (ATR) 0.83 2.80
MACD -0.48 1.49
Stochastic Oscillator 4.01 96.72

Price Performance

Historical Comparison
REPL
ATLC

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About ATLC Atlanticus Holdings Corporation

Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.

Share on Social Networks: